Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
1430000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of the 12th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment provision)
発行・処分する株式数1,430,000Shares
1,430,000 new shares
Intended allottee
EVO FUND
Existing Shares and Increase
+14.30%Rate of increase
14,779,000 shares16,209,000Shares
Exercise ratio since the beginning of the month: 14.30% (as a percentage of the total number of the 12th Stock Acquisition Rights issued)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥104 (1 September 2026)
Number of Stock Acquisition Rights
Total issued: 100,000 rights; unexercised as of the end of the previous month: 95,260 rights; currently unexercised: 80,960 rights
Most recent equity financing
Issued on 7 August 2026: issuance of the 12th Stock Acquisition Rights through a third-party allotment (with an exercise price adjustment clause) and the 3rd unsecured corporate bonds (privately placed). See the materials released on 22 July 2026 for details.
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of the 12th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment provision) |
| Number of shares to be issued or disposed of | 1,430,000 new shares |
| Intended allottee | EVO FUND |
| Dilution Rate | Exercise ratio since the beginning of the month: 14.30% (as a percentage of the total number of the 12th Stock Acquisition Rights issued) |
| Total number of issued shares | 14,779,000 shares (as of the end of the previous month) → 16,209,000 shares (assuming the number of shares delivered in this transaction is added to the number of issued shares as of the end of the previous month) |
| Exercise price | ¥104 (1 September 2026) |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; unexercised as of the end of the previous month: 95,260 rights; currently unexercised: 80,960 rights |
| Most recent equity financing | Issued on 7 August 2026: issuance of the 12th Stock Acquisition Rights through a third-party allotment (with an exercise price adjustment clause) and the 3rd unsecured corporate bonds (privately placed). See the materials released on 22 July 2026 for details. |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company does not state a reason.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.